In association with
Logo Logo Logo

In five days, Suryavanshi earned Rs 100 crore


MUMBAI:- Aiming at Diwali, the Bollywood multi-starrer film ‘Suryavanshi’, which was released on November 6, is making huge profits along with India. At the Indian box office, the film has set a record in terms of earnings. The film, which grossed Rs 262.9 million, has managed to cross the Rs 100 crore mark in five days of release

The film earned Rs 238.5 million on the second day, Rs 269.4 million on the third day, Rs 145.1 million on the fourth day and Rs 112.2 million on the fifth day (yesterday), said trade analyst Taran Adarsh. In the five days since its release, the film has grossed Rs 128.1 million. ‘Suryavanshi’ has become the first film to make a business of Rs 100 crore in India after the Corona epidemic.

This film is doing aggressive business even in Nepal. It is learned that the film has sold close to 30 million copies in five days in Nepal. Directed by Rohit Shetty, the film stars Akshay Kumar, Katrina Kaif, Ajay Devgn and Ranbir Singh. Akshay’s acting and action in the film is very much liked by the audience. The film is estimated to hit 20 million in India alone.

For Indian tourists travelling by land:- 72 hours (-ve) C-19 report, CCMC form and Antigen Test at entry point

For Indian tourists travelling by land:- 72 hours (-ve) C-19 report, CCMC form and Antigen Test at entry point

Comment here !
Related News

KATHMANDU:- Dolpa filming of Laxman Sunar directed film ‘Bulaki’ has been completed. The filming of Dolpa has been completed on

KATHMANDU:- Actor Shivahari Poudel’s first film ‘Lakka Jawan’ has announced its release date. The film, which was not allowed to

KATHMANDU:- The 19th edition of Nepal’s prestigious film festival ‘Kathmandu International Film Festival’ (KIMF) is scheduled to be held from

By Birat Anupam, ITAHARI:- Sadhana Music Academy of Itahari is organizing 3-day-long orchestra festival starting from December 7. The first


Headlines
Information for Indian tourists travelling by land:- 72 hours (-) C-19 report, CCMC form and Antigen Test at entry point